type stringclasses 2
values | gt_table stringlengths 116 12.6k | image imagewidth (px) 109 761 |
|---|---|---|
simple | <table><tr><td></td><td>Group I</td><td>Group II</td></tr><tr><td>Chemotherapy cycles</td><td>5 (3-6) *</td><td>5 (1-6) *</td></tr><tr><td>>4 cycles</td><td>14 (87%) *</td><td>12 (80%) *</td></tr><tr><td>EBRT dose</td><td>40 (40-66) *</td><td>40 (40-66) *</td></tr><tr><td>Dose to point A</td><td>33 (5-52) *</td><td>... | |
complex | <table><tr><td rowspan="2">Characteristics</td><td colspan="2">Unstandardized Coefficients</td><td>Standardized Coefficients</td><td rowspan="2">t</td><td rowspan="2">Sig.</td></tr><tr><td>B</td><td>Std. Error</td><td>Beta</td></tr><tr><td>SBP</td><td>−0.003</td><td>0.003</td><td>−0.104</td><td>− 0.94... | |
simple | <table><tr><td>Author</td><td>Year</td><td>Population</td><td>Sample size</td><td>Method</td><td>Cut-off</td><td>miRNA</td><td>Survival analysis</td><td>Source of HR</td><td>Follow-up (month)</td></tr><tr><td>Luo</td><td>2015</td><td>China</td><td>88</td><td>qRT-PCR</td><td>Median</td><td>miR-26b</td><td>OS, RFS</td><t... | |
simple | <table><tr><td><i>Variables</i></td><td><i>Group 1 n (%)</i></td><td><i>Group 2 n (%)</i></td><td><i>p</i></td></tr><tr><td>Men</td><td>30 (88.2)</td><td>16 (69.6)</td><td>0.09</td></tr><tr><td>Age</td><td>65.94 ± 6.67</td><td>65.78 ± 9.29</td><td>0.9</td></tr><tr><td>Previous MI</td><td>9 (26.5)</td><td>6 (2... | |
simple | <table><tr><td> </td><td>Mean (±SD) nuclear gray level</td></tr><tr><td>Normal urothelium (NU), global</td><td>106±15</td></tr><tr><td>NU, superficial epithelial layer</td><td>104±15</td></tr><tr><td>NU, intermediate cell layers</td><td>106±15</td></tr><tr><td>NU, basal cell layer</td><td>108±1... | |
simple | <table><tr><td>Study Authors</td><td>Best Model/Main Finding</td><td>Subsequent Criticisms</td></tr><tr><td>Hubbell (2001)</td><td>ZSM</td><td>Goodness of fit only determined by graphical observation.</td></tr><tr><td>McGill (2003)</td><td>ZSM does not fit the data better than the lognormal</td><td>Used simulations to ... | |
complex | <table><tr><td>Function units</td><td>Known or possible role</td><td>References</td></tr><tr><td colspan="3">ULK1 complex</td></tr><tr><td>ULK1</td><td>Binds with ATG13, ATG101, and FIP200</td><td>[19, 20, 163]</td></tr><tr><td>ATG13</td><td>Bridges the interaction of ULK1 and FIP200; is required for the localization a... | |
simple | <table><tr><td>Compound code</td><td>SiHa</td><td>B16F10</td><td>K562</td><td>Chang</td></tr><tr><td>1T</td><td>7.17 ± 0.3</td><td>5.16 ± 0.5</td><td>> 10.00</td><td>7.91 ± 0.4</td></tr><tr><td>2T</td><td>7.14 ± 0.5</td><td>7.63 ± 0.4</td><td>> 10.00</td><td>> 10.00</td></tr><tr><td>3T... | |
complex | <table><tr><td rowspan="2">Factors of association<sup>a</sup></td><td colspan="3">All (n = 3458)</td><td colspan="3">Uganda (n = 491)</td></tr><tr><td>Adjusted OR</td><td>95 % CI</td><td>P value</td><td>Adjusted OR</td><td>95 % CI</td><td>P value</td></tr><tr><td>UC allocation by sleeping place (vs by people)</td><td>1... | |
complex | <table><tr><td rowspan="2" colspan="2">Stratified characteristics</td><td colspan="3">Cases [<i>n</i>(%)]</td><td colspan="4">Controls [<i>n</i>(%)]</td><td rowspan="2">AA</td><td colspan="2">AG</td><td colspan="2">GG</td></tr><tr><td>AA</td><td>AG</td><td>GG</td><td colspan="2">AA</td><td>AG</td><td>GG</td><td><i>p*</... | |
simple | <table><tr><td>Set</td><td>Description</td><td>Min</td><td>Max</td><td>Mean</td><td>Median</td><td>St.dev.</td></tr><tr><td>1</td><td>Training Set (32 articles)</td><td>4</td><td>147</td><td>19</td><td>14</td><td>24</td></tr><tr><td>2</td><td>Test Set (50 articles – gold standard)</td><td>0</td><td>375</td><td>33... | |
complex | <table><tr><td> </td><td>Intervention arm<i>n/N</i>(%, 95% CI)</td><td>Standard invitation arm<i>n/N</i>(%, 95% CI)</td></tr><tr><td colspan="3">Possible unintended consequences</td></tr><tr><td>Parents made an informed decision</td><td>28/54 (51.9, 26.7–76.1)</td><td>9/33 (27.3, 7.6–63.2)</td></tr><tr><td ... | |
simple | <table><tr><td>Cluster</td><td>n</td><td>%</td><td>Cluster group<sup>1</sup></td><td>Pulsotype</td><td>n</td><td>%</td><td>Pulsotype group<sup>1</sup></td></tr><tr><td>C1</td><td>6</td><td>3.2</td><td>Less common</td><td>C1a</td><td>3</td><td>1.6</td><td>Less common</td></tr><tr><td> </td><td> </td><td> </td><td> </td>... | |
simple | <table><tr><td>Respiratory rate</td><td>Group I (Magnesium) mean ± SD</td><td>Group II (Control) mean ± SD</td><td><i>P</i>-value</td></tr><tr><td>After induction</td><td>23.8 ± 0.6</td><td>30.2 ± 1.3</td><td>0.001*</td></tr><tr><td>10 min.</td><td>23.8 ± 0.6</td><td>28.3 ± 1.3</td><td>0.0... | |
simple | <table><tr><td>Elements</td><td>GP (genome proportion, %)</td></tr><tr><td>Retrotransposon</td><td>11.05</td></tr><tr><td> Copia</td><td>5.81</td></tr><tr><td> Gypsy</td><td>4.88</td></tr><tr><td> LINE/SINE</td><td>0.33</td></tr><tr><td> Unclassified LTR</td><td>0.03</td></tr><tr><td>Transposon</td><td>1.41</td></tr><t... | |
complex | <table><tr><td rowspan="2">Characteristic</td><td colspan="2">Non-recurrent</td><td colspan="2">Metachronous metastasis</td><td rowspan="2">p-value<sup>1</sup></td></tr><tr><td>absolute</td><td><i>%</i></td><td>absolute</td><td><i>%</i></td></tr><tr><td>Total number</td><td>33</td><td> </td><td>12</td><td> </td><td> </... | |
simple | <table><tr><td></td><td>Cortical region</td></tr><tr><td>1</td><td>Banks of the superior temporal sulcus</td></tr><tr><td>2</td><td>Caudal anterior cingulate</td></tr><tr><td>3</td><td>Caudal middle frontal</td></tr><tr><td>4</td><td>Cuneus</td></tr><tr><td>5</td><td>Entorhinal</td></tr><tr><td>6</td><td>Frontal pole</... | |
simple | <table><tr><td></td><td>Healthy weight</td><td>Increased weight</td></tr><tr><td>Persistent oligoarthritis</td><td>95 (90.5)</td><td>10 (9.5)</td></tr><tr><td>ERA</td><td>55 (68)</td><td>26 (32)</td></tr><tr><td>Poliarthritis RF (+)</td><td>46 (78)</td><td>13 (22)</td></tr><tr><td>Systemic</td><td>28 (90.5)</td><td>1 (... | |
complex | <table><tr><td>Function</td><td>Genes</td><td></td><td>Fold change</td></tr><tr><td rowspan="4">Intestinal peptides</td><td>GIP</td><td>Glucose inhibitory peptide</td><td>−1.72</td></tr><tr><td>GKN1</td><td>Gastrokine 1</td><td>−1.54</td></tr><tr><td>GKN2</td><td>Gastrokine 2</td><td>−1.51</td></tr><t... | |
complex | <table><tr><td rowspan="2" colspan="2"> </td><td colspan="2">Hospital plan for follow-up</td></tr><tr><td>General practitioner (n = 23)</td><td>Specialist health service (n = 66)</td></tr><tr><td rowspan="2">Hospital guidelines for follow-up</td><td>General practitioner (n = 11)</td><td>3</td><td>8</td></tr><tr><td>Spe... | |
simple | <table><tr><td>Viral Systems</td><td>Copolymers</td><td>Genes</td><td>Targets</td><td>Administration</td><td>Observations</td><td>References</td></tr><tr><td>rAAV</td><td>Pluronic<sup>®</sup> F127</td><td>GM-CSF</td><td>solid tumors</td><td>in vivo intratumoral infusion (mouse)</td><td>higher efficiency by combini... | |
complex | <table><tr><td rowspan="2"></td><td colspan="2">Dispensation rate of generics</td><td rowspan="2"><i>P</i></td></tr><tr><td>Pre-adoption[% (drugs/total drugs)]</td><td>Post-adoption[% (drugs/total drugs)]</td></tr><tr><td>All drugs subjected to analysis</td><td>48.3 (447/926)</td><td>57.7 (604/1046)</td><td>< 0.001<... | |
complex | <table><tr><td>Descriptor</td><td colspan="3">P-values</td></tr><tr><td></td><td>Not ranked</td><td>30 Top-ranked</td><td>20 Top-ranked</td></tr><tr><td>C</td><td>1.2 e-1</td><td>5.8 e-1</td><td>5.6 e-1</td></tr><tr><td>D</td><td>5.1 e-3</td><td>2.6 e-1</td><td>2.4 e-1</td></tr><tr><td>Variance</td><td>9.0 e-2</td><td>... | |
simple | <table><tr><td>Migraine Triggers</td><td>N</td><td>%</td></tr><tr><td>Identified any Triggers</td><td>3416</td><td>82.9</td></tr><tr><td>Stress</td><td>2669</td><td>55.8</td></tr><tr><td>Environment (weather, etc...)</td><td>2870</td><td>60.0</td></tr><tr><td>Lack of Sleep</td><td>2484</td><td>51.9</td></tr><tr><td>Hor... | |
simple | <table><tr><td>Group</td><td>Cohesive fracture in tooth</td><td>Cohesive fracture in laminate</td><td>Adhesive</td><td>Mixed cohesive and adhesive</td></tr><tr><td>Control</td><td>5</td><td>1</td><td>0</td><td>5</td></tr><tr><td>SC</td><td>4</td><td>0</td><td>3</td><td>4</td></tr><tr><td>LC</td><td>1</td><td>0</td><td>... | |
complex | <table><tr><td></td><td>Number</td><td>NLR</td><td>PNI</td></tr><tr><td>All cases</td><td>334</td><td>2.52 ± 2.06</td><td>51.03 ± 5.72</td></tr><tr><td colspan="4"> Age</td></tr><tr><td> ≦70</td><td>165</td><td>2.34 ± 1.91</td><td>52.20 ± 5.38*</td></tr><tr><td> >70</td><td>169</td><td>2.69... | |
simple | <table><tr><td>PAMAM dendrimer generation (G)</td><td>Terminal amines (#)</td><td>Naked dendrimer molecular weight (kDa)</td><td>Gd-G5-doxorubicin dendrimer molecular weight (kDa)</td><td>Gd-DTPA conjugation (%)</td><td>Doxorubicin conjugation (%)</td><td>Molar relaxivity (mM<sup>-1</sup>s<sup>-1</sup>)</td></tr><tr><t... | |
complex | <table><tr><td rowspan="2">Temperature E (°C)</td><td rowspan="2">Dry weight of mycelial mat (mg/flask)</td><td rowspan="2">Protein content (mg/ml)</td><td colspan="3">Cellulase</td></tr><tr><td><sup>a</sup>FPase (FPU/ml)</td><td><sup>b</sup>CMCase (U/ml)</td><td><sup>c</sup>Β-glucosidase (U/ml)</td></tr><tr>... | |
complex | <table><tr><td>Group</td><td>Method</td><td>Sensitivity (%)</td><td>Specificity (%)</td><td>False positives (%)</td><td>False negatives (%)</td></tr><tr><td rowspan="4"><i>Classical</i></td><td>Fisher</td><td>59.18</td><td>88.64</td><td>5.89</td><td>40.82</td></tr><tr><td>Sidak</td><td>18.37</td><td>97.73</td><td>0.11<... | |
complex | <table><tr><td></td><td colspan="3">2013–2014 Change</td><td colspan="3">2014–2015 Change</td></tr><tr><td>Runs Per Game</td><td>5.8</td><td>8.6</td><td>48%</td><td>8.6</td><td>9.4</td><td>9%</td></tr><tr><td>Batting Average</td><td>0.286</td><td>0.326</td><td>14%</td><td>0.326</td><td>0.324</td><td><1%<... | |
simple | <table><tr><td> </td><td>Lean group</td><td>Obese group</td><td>Obese GDM group</td><td>P-value<sup>1</sup></td><td>Adjusted p-value<sup>2</sup></td></tr><tr><td>Weight [g]</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Birth</td><td>3,449 ± 332 [15]</td><td>3,651 ± 285 [13]</td><td>3,617 ... | |
simple | <table><tr><td>Age MTfer</td><td>Mean age</td><td>Number</td></tr><tr><td>Posetive</td><td>50.75</td><td>4</td></tr><tr><td>Negative</td><td>40.60</td><td>42</td></tr><tr><td>Total</td><td>41.48</td><td>46</td></tr></table> | |
simple | <table><tr><td>Health centre</td><td># fulltime professionals in labour ward</td><td>Midwives</td><td>Obstetric bed</td><td>Delivery couch</td><td># deliveries in the last month</td></tr><tr><td>Woreda 7</td><td>6</td><td>6</td><td>4</td><td>2</td><td>40</td></tr><tr><td>Bole 17</td><td>10</td><td>8</td><td>11</td><td>... | |
simple | <table><tr><td>microRNAs</td><td>Location on chromosome</td><td>WT</td><td>WT+UVR</td><td>Log Fold Change</td><td>Adjusted <i>p</i>-value</td><td>Total # of gene targets</td></tr><tr><td>miR-127-3p</td><td>chr12: 109592846-109592915 [+]</td><td>1.089</td><td>−0.401</td><td>−1.49</td><td>1.11E-06</td><td>12<... | |
complex | <table><tr><td rowspan="2"></td><td>Group 1</td><td>Group 2</td><td rowspan="2">P values</td></tr><tr><td>NSRT</td><td>SRT</td></tr><tr><td rowspan="2">Number of retinal tears per eye</td><td>1.42 ± 0.8 (<i>r</i> = 1-5)</td><td>1.36 ± 0.5 (<i>r</i> = 1-2)</td><td rowspan="2">0.54</td></tr><tr><td>n (%)</td><t... | |
complex | <table><tr><td rowspan="2"></td><td>Total number of patients</td><td>Fibromyalgia+</td><td>Fibromyalgia-</td><td rowspan="2"><i>P</i></td></tr><tr><td>(n = 196)</td><td>(n = 42)</td><td>(n = 154)</td></tr><tr><td>Patients who received at least one TNFi</td><td>141 (71.9 %)</td><td>33 (78.6 %)</td><td>108 (70.1 %)</td><... | |
simple | <table><tr><td>Categories and Themes and No. of participants disclosing the theme</td></tr><tr><td>Category 1: The experience of maladaptive coping responses and the perceived barriers to recovery</td></tr><tr><td>Isolating self from social support (6/8)</td></tr><tr><td>Using alcohol to gain temporary relief and to bo... | |
complex | <table><tr><td>N= 29,157,460</td><td>%</td></tr><tr><td colspan="2">Sex</td></tr><tr><td> Male</td><td>49.9</td></tr><tr><td> Female</td><td>50.1</td></tr><tr><td colspan="2">Age</td></tr><tr><td> 6 to 11</td><td>7.4</td></tr><tr><td> 12 to 19</td><td>11.4</td></tr><tr><td> 20 to 39</td><td>30.9</td></tr><tr><td> 40 to... | |
simple | <table><tr><td>Variable</td><td>CaseN(%)</td><td>ControlN(%)</td><td><i>χ</i><sup><i>2</i></sup></td><td><i>P</i></td></tr><tr><td>Hypertension</td><td></td><td></td><td>4.625</td><td>0.032</td></tr><tr><td> Yes</td><td>189 (12.8)</td><td>152 (10.3)</td><td></td><td></td></tr><tr><td> No</td><td>1285 (87.2)</td><t... | |
simple | <table><tr><td>Target mRNA</td><td>Sequence(5’-3’)</td><td>Product size</td></tr><tr><td>(Accession number)</td><td> </td><td>(bp)</td></tr><tr><td>hOCT1/<i>SLC22A1</i></td><td>AATGGACCACATCGCTCAAAA</td><td> </td></tr><tr><td>(NM_003057)</td><td>CTTCGAGGGAAAGCATCTTTAAAT</td><td>68</td></tr><tr><td>hOCT2/<i>... | |
simple | <table><tr><td></td><td>Total</td><td>HPV awareness</td><td>Prevalence ratio</td><td>95% CI</td><td>P</td></tr><tr><td>Age at first sexual intercourse</td><td></td><td></td><td></td><td></td><td>0.307</td></tr><tr><td> ≤15</td><td>132</td><td>33.3%</td><td>1</td><td></td><td></td></tr><tr><td> > 15</td><td>169... | |
complex | <table><tr><td>Item</td><td colspan="3">People with diabetes are advised to regularly check their feet and the inside of their shoes. People differ a lot with respect to the importance they attach to “good advice“ of this kind. How important is this advice for you personally?</td></tr><tr><td>Reply options<... | |
simple | <table><tr><td>Area</td><td>Sex</td><td>Age (years)</td><td>No. at the 1st <sup>1)</sup></td><td>No. at the 2nd <sup>2)</sup></td><td>Seroconversion rate (%)</td></tr><tr><td>Trial</td><td>Male</td><td>2-5</td><td>1</td><td>0</td><td>0</td></tr><tr><td> </td><td> </td><td>>5</td><td>15</td><td>12</td><td>80.0</td></... | |
simple | <table><tr><td>Parameter</td><td>Calcium Diphosphate</td><td>Chitin</td><td>Lactose H<sub>2</sub>O</td><td>Avicel PH 101</td><td>Starch 1500</td><td>PVP K30</td><td>Sorbitol</td></tr><tr><td><i>P<sub>Y</sub></i></td><td>250.1</td><td>122</td><td>150</td><td>62.5</td><td>75.1</td><td>35.7</td><td>48.4</td></tr><tr><td><... | |
simple | <table><tr><td></td><td></td><td>No ETOH Group (<i>n</i> = 1,445)</td><td>Low ETOH Group (<i>n</i> = 273)</td><td>High ETOH Group (<i>n</i> = 605)</td><td>Total (<i>n</i> = 2,323)</td><td><i>P</i> value<sup>#</sup></td></tr><tr><td>Severe head injury</td><td>%</td><td>66.5</td><td>68.5</td><td>59.8</td><td>64.85</td><t... | |
simple | <table><tr><td>Type</td><td>Method</td><td>Gold standard fusion genes detected</td><td>Sensitivity<sup>b</sup></td><td>Total fusion genes detected</td><td>Precision</td><td>F-score</td></tr><tr><td>SGS + TGS</td><td>IDP-fusion 2LR + 2SR<sup>a</sup></td><td>24</td><td>33.80%</td><td>35</td><td>68.57%</td><td>0.4528</td>... | |
simple | <table><tr><td>Patient ID</td><td>Sample ID</td><td>Gender</td><td>Age at test</td><td>Type of cancer</td><td>Sample type</td></tr><tr><td>1</td><td>F1311260008</td><td>Female</td><td>64</td><td>Lung cancer, SCC</td><td>FFPE</td></tr><tr><td>2</td><td>B1312160009</td><td>Female</td><td>61</td><td>Colon cancer</td><td>B... | |
complex | <table><tr><td rowspan="2" colspan="2">Variables</td><td colspan="2">Watching porn videos</td><td colspan="2">Attending night clubs</td><td colspan="2">Sex with commercial sex workers</td></tr><tr><td>COR (95% CI)</td><td>AOR (95% CI)</td><td>COR (95% CI)</td><td>AOR (95% CI)</td><td>COR (95% CI)</td><td>AOR (95% CI)</... | |
simple | <table><tr><td>Variable†</td><td></td><td>Odds ratio</td><td>95% CI‡</td></tr><tr><td>Pretreatment HCV RNA level§</td><td>Per 1 log increase</td><td>0.179</td><td>0.096–0.336</td></tr><tr><td>HCV genotype</td><td>1b = 1; non-1b = 0</td><td>0.324</td><td>0.151–0.695</td></tr><tr><td>IFN-^... | |
simple | <table><tr><td>Family</td><td>Millet Zhang gu</td><td>Millet Yugu1</td><td>Maize</td></tr><tr><td>AUX/IAA</td><td>29</td><td>29</td><td>52</td></tr><tr><td>GIF</td><td>3</td><td>3</td><td>3</td></tr><tr><td>MBF1</td><td>2</td><td>2</td><td>3</td></tr><tr><td>Med10</td><td>1</td><td>1</td><td>2</td></tr><tr><td>Med11</t... | |
complex | <table><tr><td>Variables</td><td colspan="2">Survival statusDead Censored</td><td>CHR (95%CI)</td><td>AHR (95%CI)</td></tr><tr><td colspan="5">Sex</td></tr><tr><td> Male</td><td>23</td><td>154</td><td>2.5 (1.3, 5.0)</td><td>1.3 (0.6, 3.0)</td></tr><tr><td> Female</td><td>15</td><td>198</td><td>1</td><td>1</td></tr><tr>... | |
complex | <table><tr><td colspan="2">Variables</td><td>Frequency</td><td>Percentage</td></tr><tr><td rowspan="4">Age</td><td>15-19 years</td><td>16</td><td>3.8</td></tr><tr><td>20-34 years</td><td>333</td><td>79.5</td></tr><tr><td>35-49 years</td><td>70</td><td>16.7</td></tr><tr><td>Mean ±SD</td><td> </td><td>(27.4 ± 6... | |
complex | <table><tr><td></td><td>Without MHC</td><td>With MHC</td><td><i>p</i>-value</td></tr><tr><td colspan="4">Patient mediated diagnostic delay (<i>N</i> = 368, %)</td></tr><tr><td> No</td><td>187 (80.26)</td><td>108 (80)</td><td rowspan="2">0.99</td></tr><tr><td> Yes</td><td>46 (19.74)</td><td>27 (20)</td></tr><tr><td cols... | |
complex | <table><tr><td rowspan="3">Nutrient Content</td><td colspan="5">Unweighted Estimates (<i>n</i> = 431 Products)</td><td colspan="5">Estimates Weighted by Household Purchase Volumes (<i>n</i> = 419 Products)</td></tr><tr><td>2014</td><td>2016</td><td rowspan="2">Mean Difference (95% CI)</td><td rowspan="2"><i>p</i>-Value... | |
complex | <table><tr><td></td><td colspan="2">Forensic autopsy</td></tr><tr><td>Molecular autopsy</td><td>+ (<i>n</i> = 26)</td><td>− (<i>n</i> = 24)</td></tr><tr><td>+ (<i>n</i> = 14)</td><td>9</td><td>5</td></tr><tr><td>− (<i>n</i> = 36)</td><td>17</td><td>19</td></tr></table> | |
complex | <table><tr><td></td><td>Women screened N</td><td>Interval tumors N</td><td>Ratio/10000 (95% IC poisson)</td><td>Sensitivity (%)</td></tr><tr><td colspan="5">50-59 initial</td></tr><tr><td>Round 1</td><td>20221</td><td>17</td><td>8.41 (8.37-8.45)</td><td>104/121 (85.95)</td></tr><tr><td>Round 2</td><td>7675</td><td>4</t... | |
complex | <table><tr><td>Assembly names</td><td>A</td><td>B</td><td>C</td><td>D</td></tr><tr><td colspan="5">Assembly tools</td></tr><tr><td>Contig assembly tool</td><td><i>Fermi</i></td><td><i>Fermi</i></td><td><i>SOAPdenovo2</i></td><td><i>SOAPdenovo2</i></td></tr><tr><td>Scaffolding tool</td><td><i>SOAPdenovo2</i></td><td><i>... | |
simple | <table><tr><td>Group</td><td>No. oocytes</td><td>Survival rate</td><td>Cleavage rate</td><td>Blastocyst rate</td></tr><tr><td>Control</td><td>132</td><td>100% ± 0 (132/132)<sup>a</sup></td><td>84.21% ± 2% (111/132)<sup>a</sup></td><td>38.62% ± 0.75% (51/132)<sup>a</sup></td></tr><tr><td>Toxicity</td><td>... | |
complex | <table><tr><td>Project</td><td>Primer sequences</td><td>Amplified fragment length</td></tr><tr><td rowspan="2">GAPDH</td><td>F: 5′ GAAGAGTGGGTGTCGCTGTT 3′</td><td rowspan="2">141 bp</td></tr><tr><td>R: 5′ CTGCCGTCTGGAAAAACCT 3′</td></tr><tr><td rowspan="2">CREB</td><td>F: 5′ GTGCCAGCCTTTCC... | |
simple | <table><tr><td>Groups</td><td>Number of clusters</td><td>Number of clones</td><td>Clones/clusters</td><td>% of total</td><td>Putative identification</td></tr><tr><td>1</td><td>542</td><td>741</td><td>1.37</td><td>24.6</td><td>No Hit*</td></tr><tr><td>2</td><td>91</td><td>489</td><td>5.37</td><td>16.3</td><td>Sphingomye... | |
simple | <table><tr><td>r<sub>A </sub>- r<sub>a</sub></td><td>Number of generations needed for the relative proportion of a clone to change from 1% to 99%</td></tr><tr><td>0.01</td><td>919</td></tr><tr><td>0.05</td><td>184</td></tr><tr><td>0.10</td><td>92</td></tr><tr><td>0.50</td><td>18</td></tr><tr><td>0.75</td><td>12</td></t... | |
simple | <table><tr><td>Sample type</td><td>Origin</td><td>Origin</td><td>Period/yearsbefore present</td><td>Numberof samples</td><td>Reference</td><td>PUBMED ID</td><td>SRA accession</td></tr><tr><td>Completeground teeth</td><td>Published works</td><td>England</td><td>750–650</td><td>6</td><td>Adler et al.<sup>9</sup></t... | |
complex | <table><tr><td rowspan="2">Value</td><td colspan="2">GENIA</td><td colspan="2">ST</td><td rowspan="2">ST(%)/GENIA(%)</td></tr><tr><td>frequency</td><td>%</td><td>frequency</td><td>%</td></tr><tr><td>Investigation</td><td>1,914</td><td>5.3</td><td>520</td><td>5.5</td><td>1.03</td></tr><tr><td>Analysis</td><td>6,412</td>... | |
simple | <table><tr><td>Disease</td><td>Cell surface DAF deficiency</td><td>Citation</td></tr><tr><td>Immune dysregulation</td><td> </td><td> </td></tr><tr><td> Sjogren's Syndrome</td><td>T-lymphocytes</td><td>[36]</td></tr><tr><td> SLE with lymphopenia and anemia</td><td>T-lymphocytes (CD8+), endothelium, lymphocytes, and anem... | |
simple | <table><tr><td>Authors</td><td>Study subjects</td><td>Substances</td><td>Insults</td><td>Results</td></tr><tr><td>Broekhuizen [67]</td><td>Patients</td><td>Sulodexide</td><td>Diabetes mellitus type 2</td><td>GCX thickness increased</td></tr><tr><td>Gao [71]</td><td>Rats</td><td>Hydrocortisone</td><td>Pancreatitis</td><... | |
complex | <table><tr><td>Region</td><td>Number tested</td><td colspan="4">Blood slide microscopy</td><td colspan="3">Rapid diagnostic test (ParaScreen)</td></tr><tr><td></td><td></td><td>Pf %</td><td>Pv %</td><td>Pf & Pv %</td><td>Total % (95%CI)</td><td>Pan/Pf %</td><td>Pan %</td><td>Total % (95%CI)</td></tr><tr><td>Amhara<... | |
complex | <table><tr><td>Lipid profile</td><td>Case Number (%)</td><td>Control Number (%)</td><td>Total subjects Number (%)</td><td><i>P</i> value<sup><i>∗</i></sup></td></tr><tr><td>Dyslipidemia</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> No</td><td>22 (18)</td><td>29 (23.8)</td><td>51 (20.9)</td><td rowspan... | |
simple | <table><tr><td>Area</td><td>Example</td><td>Potential utility</td><td>Limitations</td></tr><tr><td>Risk prediction</td><td>Predict new-onset AF or AF-related morbidity (stroke, heart failure, mortality risk)</td><td>Benchmark for clinical trial development</td><td>Absence of known preventive strategies for AF</td></tr>... | |
simple | <table><tr><td>Group</td><td>Number of Subjects</td><td>Average Age (Range)</td><td>Average Height, cm</td><td>Average Mass kg</td><td>Average Vital Capacity, L</td></tr><tr><td>Females</td><td>29</td><td>25.5 ± 3.7 (18 to 31)</td><td>164 ± 6</td><td>60.5 ± 13.3</td><td>3.58 ± 0.63</td></tr><tr><td>... | |
simple | <table><tr><td>History</td><td> No abnormality on IPS</td><td>Abnormality on IPS</td><td>Total</td></tr><tr><td>Family history of epilepsy</td><td>16</td><td>0</td><td>16</td></tr><tr><td>Consanguinity</td><td>14</td><td>1</td><td>15</td></tr><tr><td>No family history</td><td>94</td><td>12</td><td>106</td></tr><tr><td>... | |
complex | <table><tr><td colspan="4">(−592 C/A) (rs1800872)</td><td colspan="4">(−819 C/T) (rs1800871)</td></tr><tr><td>Genotype</td><td>n(%)SICL/(%)NCL (n = 204/166)</td><td>ORa (IC95%)</td><td>p Value*</td><td>Genotype</td><td>n(%)SICL/(%)NCL (n = 204/166)</td><td>ORa (IC95%)</td><td>p Value*</td></tr><tr><td colsp... | |
simple | <table><tr><td>Locus</td><td>SNP</td><td>Gene</td><td>eQTL <i>P</i><sub>all</sub></td><td>eQTL <i>P</i><sub>ER+</sub></td><td>DSS <i>P</i><sub>ER+</sub></td><td>727 cancer genes source</td></tr><tr><td>2q31.1</td><td>rs1550623</td><td><i>CDCA7</i></td><td>0.007 (0.09)</td><td>0.51 (0.67)</td><td>4 × 10<sup>−... | |
simple | <table><tr><td>Group</td><td>Number</td><td>Age, years</td><td>Years of education</td><td>MMSE</td><td>ACE-R</td><td>PSP-RS</td></tr><tr><td>Alzheimer’s disease</td><td>17</td><td>71 (9)</td><td>14 (3)</td><td>25 (4)</td><td>72 (14)</td><td>-</td></tr><tr><td>PSP</td><td>17</td><td>69 (6)</td><td>12 (2)</td><td>2... | |
simple | <table><tr><td>Types of substance</td><td>Frequency </td><td>Percent </td></tr><tr><td>Alcohol use (<i>n</i> = 489)</td><td> </td><td> </td></tr><tr><td> Yes</td><td>42</td><td>8.6</td></tr><tr><td> No</td><td>447</td><td>91.4</td></tr><tr><td>Period of alcohol use (<i>n</i> = 42)</td><td> </td><td> </td></tr><tr><td> ... | |
simple | <table><tr><td>Food group</td><td>Items awarded 1 point</td><td>ARFS</td></tr><tr><td>Vegetables</td><td>>4 vegetables per day; potatoes cooked without fat; tomatoes fresh/canned; lettuce/endive/salad greens; carrots; cabbage/brussels sprouts; cauliflower; broccoli; celery; silver beet or spinach; peas; green beans;... | |
complex | <table><tr><td>Dimension</td><td>Value</td><td>Count</td><td>R / P / F</td><td>+GENIA (R/P/F)</td><td>Majority (R/P/F)</td></tr><tr><td rowspan="6">KT</td><td>Investigation</td><td>38</td><td>76.3 / 67.4 / 71.6</td><td>68.4 / 65.0 / 66.7</td><td>0.0 / 0.0 / 0.0</td></tr><tr><td>Analysis</td><td>132</td><td>70.5 / 69.9 ... | |
complex | <table><tr><td rowspan="2"></td><td rowspan="2">Sex</td><td rowspan="2">Age</td><td colspan="2">Pressure (mmHg)</td><td colspan="2">Echo Vol (ml)</td><td rowspan="2">Echo EF (%)</td><td rowspan="2">Patient MI and catheter information</td></tr><tr><td>Min</td><td>Max</td><td>Min</td><td>Max</td></tr><tr><td colspan="9">... | |
complex | <table><tr><td rowspan="2">Clinicopathologic features</td><td rowspan="2">Cases<i>N</i> (%)</td><td colspan="2">miR‐133b expression</td><td rowspan="2"><i>P</i></td></tr><tr><td>Low (%)</td><td>High (%)</td></tr><tr><td colspan="5">Gender</td></tr><tr><td>Male</td><td>94 (64.4)</td><td>42 (44.7)</td><td>52 (55.3)... | |
simple | <table><tr><td>Group</td><td>DEG</td><td>Fold change (log2,</td></tr><tr><td></td><td></td><td><i>vs.</i> Model)</td></tr><tr><td>Martynoside</td><td><i>Rny1</i> (RNA, Y1 small cytoplasmic, Ro-associated)</td><td>-7.74</td></tr><tr><td></td><td><i>Hist1h4a</i> (histone cluster 1, H4a)</td><td>-1.85</td></tr><tr><td></t... | |
simple | <table><tr><td>IPTG μM</td><td>OD620</td><td>Isopentenol mg/L</td></tr><tr><td>0.01</td><td>0.014</td><td>3.6</td></tr><tr><td>0.05</td><td>0.079</td><td>5.9</td></tr><tr><td>0.1</td><td>0.127</td><td>8.45</td></tr><tr><td>0.2</td><td>0.179</td><td>12.5</td></tr><tr><td>0.5</td><td>0.456</td><td>98.1</td></tr><tr>... | |
simple | <table><tr><td>Radiologic Impression/Technique</td><td>Patient</td><td>BI-RADS Category</td><td>Needle Gauge (G)</td><td>Pieces of tissue in specimen</td><td>Pieces of tissue imaged</td><td>Pathologic diagnosis</td></tr><tr><td>Calcium positive/mammogram</td><td>1</td><td>4</td><td>11</td><td>7</td><td>1</td><td>Fibroc... | |
simple | <table><tr><td>Studies</td><td>Patients</td><td>Inter- ventions</td><td>Relevant outcomes</td><td>Size of effect</td><td>Benefits and harms</td><td>Factors influencing the clinical relevance</td></tr><tr><td>Barker et al. (2008) [15]</td><td>YES</td><td>NO</td><td>NO</td><td>NO</td><td>YES</td><td>Patients: Pre-treatme... | |
complex | <table><tr><td></td><td colspan="2">IORT</td><td colspan="2">APBI</td><td colspan="2">EBRT</td></tr><tr><td></td><td>%Vol > 0.1 Gy</td><td>%Vol > 4 Gy</td><td>%Vol > 0.1 Gy</td><td>%Vol > 4 Gy</td><td>%Vol > 0.1 Gy</td><td>%Vol > 4 Gy</td></tr><tr><td>Ipsilateral Breast</td><td>84.5</td><td>18.1</td><... | |
complex | <table><tr><td rowspan="2">Variable</td><td rowspan="2">Treatment</td><td colspan="2">Time (h)</td><td rowspan="2">p-level</td></tr><tr><td>0</td><td>2</td></tr><tr><td>Cholesterol</td><td>PLA</td><td>170.6 ± 34.6</td><td>182.8 ± 35.1</td><td rowspan="3">0.006</td></tr><tr><td rowspan="2">(mg/dl)</td><td>PWS<... | |
complex | <table><tr><td>Cox model*</td><td>Factors</td><td>HR (95% CI)</td><td><i>P</i></td></tr><tr><td colspan="4">TTP</td></tr><tr><td>Gabor filter 0 Subgroups</td><td>TACE+sorafenib</td><td></td><td>0.002</td></tr><tr><td></td><td>Gabor-1-90 ≤3.6190</td><td>0.802 (0.505–1.274)</td><td></td></tr><tr><td></td><td>... | |
simple | <table><tr><td>Sections</td><td>Multidisciplinary expertise</td><td>Hardware</td><td>Software</td></tr><tr><td>2.1: Fluorescent protein behavior</td><td>Molecular biology, biochemistry</td><td>n.a.</td><td>n.a.</td></tr><tr><td>2.2–2.4: Microscopy</td><td>Cell biology, biophysics, optics</td><td>Microscope contro... | |
complex | <table><tr><td> </td><td>Total n</td><td>Ate fish (%)</td><td>Mean ounces of fish consumed in last month of pregnancy (+/- SD)</td><td>MeHg concentration in cord blood ≥5 μg/L</td></tr><tr><td>Total</td><td>100</td><td>86.0 (86)</td><td>19.8 (3.7)</td><td>44.0 (44)</td></tr><tr><td>Race**</td><td> </td><td> ... | |
complex | <table><tr><td>Marker alleles</td><td>Chromosome (linked genes)</td><td>Position</td><td colspan="6">Alleles belong to the</td></tr><tr><td></td><td></td><td></td><td>20 best</td><td>10 best</td><td>5 best</td><td>20 worst</td><td>10 worst</td><td>5 worst</td></tr><tr><td>GWM1130_109bp<sup>*</sup></td><td>1B</td><td>0<... | |
complex | <table><tr><td>Organ</td><td colspan="2">REP1 expression</td><td>Total (<i>N</i>)</td><td><i>P</i>-value</td></tr><tr><td> </td><td>−/+ <i>N</i> (%)</td><td>++/+++ <i>N</i> (%)</td><td> </td><td> </td></tr><tr><td colspan="5"><i>Cervical</i></td></tr><tr><td> Normal</td><td>4 (100.0%)</td><td>0 (0.0%)</td><td>4</... | |
simple | <table><tr><td>Site</td><td>Number</td><td>Morphology</td><td>Number</td><td>Comorbid diseases</td><td>Number</td></tr><tr><td>Local recurrence alone</td><td>4 (12.9%)</td><td>Adenocarcinoma</td><td>4 (12.9%)</td><td>Hypertension Diabetes</td><td>2 (6.4%) 2 (6.4%)</td></tr><tr><td>Pelvic lymph node</td><td>3 (9.6%)</td... | |
simple | <table><tr><td>Patient</td><td>Target lesion</td><td>SUV<sub>max</sub> pre<sup>a</sup></td><td>SUV<sub>max</sub> post<sup>b</sup></td><td>ΔSUV<sub>max</sub><sup>c</sup> (%)</td><td>RECIST<sup>d</sup></td></tr><tr><td>1</td><td>Mediastinal mass</td><td>10.00</td><td>7.50</td><td>−25</td><td>PR</td></tr><tr><t... | |
complex | <table><tr><td rowspan="2">Protocol</td><td colspan="4">Contig assembly</td><td colspan="4">Scaffolding</td></tr><tr><td>Unamplified</td><td>Phi</td><td>Tre</td><td>Rap</td><td>Unamplified</td><td>Phi</td><td>Tre</td><td>Rap</td></tr><tr><td>Assembly size (bp)</td><td>94 641 187</td><td>94 028 877</td><td>94 541 978</t... | |
complex | <table><tr><td>No.</td><td>Location</td><td colspan="2">RT-PCR</td><td colspan="2">Single RT-qPCR</td><td colspan="2">Duplex RT-qPCR</td></tr><tr><td> </td><td> </td><td>ACLSV</td><td>CGRMV</td><td>ACLSV</td><td>CGRMV</td><td>ACLSV</td><td>CGRMV</td></tr><tr><td>1</td><td>Qingdao</td><td> </td><td>+</td><td> </td><td>+... | |
simple | <table><tr><td>Region</td><td>County</td><td>Number of sites</td><td>Number of patients enrolled</td></tr><tr><td>Global <i>(total)</i></td><td> </td><td>114</td><td>1931</td></tr><tr><td>WEC <i>(total)</i></td><td> </td><td>74</td><td>760</td></tr><tr><td> </td><td>Austria</td><td>3</td><td>18</td></tr><tr><td> </td><... | |
simple | <table><tr><td>Characteristic</td><td>Overall<i>n</i>=92 (%)</td><td>Culture methods 41 (%)</td><td>Molecular diagnosis 51 (%)</td></tr><tr><td>Treatment with first-line drug regimen (%)</td><td>92 (100)</td><td>41 (100)</td><td>51 (100)</td></tr><tr><td>Mean days on first-line drug (range) (<i>n</i>=92)</td><td>81 (14... | |
complex | <table><tr><td><i>Patient</i></td><td colspan="3"><i>JAK2 p.V617F allele burden (%)</i>a</td><td colspan="3"><i>MPL p.W515L allele burden (%)</i></td><td><i>Additional mutations by NGS in DNA from GR (allele burden)</i></td><td><i>HUMARA</i></td></tr><tr><td> </td><td><i>RNA platelets</i></td><td><i>RNA GR</i></td><td>... | |
simple | <table><tr><td>Patient no.</td><td>Age (years)</td><td>Diagnosis</td><td>Stage</td><td>Therapy</td></tr><tr><td>1</td><td>29</td><td>HD, MC</td><td>IIA</td><td>MOPP × 6, Mantle 36 Gy</td></tr><tr><td>2</td><td>28</td><td>HD, NS</td><td>IIB</td><td>MOPP × 4, ABVD × 4, Mantle 20 Gy</td></tr><tr><td>3</td><... | |
simple | <table><tr><td>Characteristics</td><td>N (%)</td></tr><tr><td>Low back pain, spine or joint disorders</td><td></td></tr><tr><td>No</td><td>315 (39.6)</td></tr><tr><td>Yes</td><td>481 (60.4)</td></tr><tr><td>Non-ischemic heart disease</td><td></td></tr><tr><td>No</td><td>433 (54.4)</td></tr><tr><td>Yes</td><td>363 (45.6... | |
complex | <table><tr><td rowspan="2">Feature</td><td rowspan="2"><i>F-score</i></td><td colspan="4">Correlation, <i>r</i></td></tr><tr><td>ss_Abs_dSize</td><td>zsEntropy21</td><td>predRSA</td><td>varPredRSA21</td></tr><tr><td>Abs_dSS</td><td>0.73</td><td>0.73</td><td>−0.72</td><td>−0.38</td><td>−0.32</td></tr><... | |
complex | <table><tr><td></td><td colspan="3">27 April 2007, end of bloom</td><td colspan="3">27 April 2008, full bloom</td><td colspan="3">9 May 2008, end of bloom</td></tr><tr><td></td><td><i>n</i></td><td>mean (<i>μ</i>L)</td><td>std</td><td><i>n</i></td><td>mean (<i>μ</i>L)</td><td>std</td><td><i>n</i></td><td>mean... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.